Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study

Arthritis and Rheumatism
D O CleggW G Henderson

Abstract

To determine whether sulfasalazine (SSZ) at a dosage of 2,000 mg/day is effective for the treatment of active psoriatic arthritis (PsA) resistant to nonsteroidal antiinflammatory drug therapy. Two hundred twenty-one patients with PsA were recruited from 15 clinics, randomized (double-blind) to SSZ or placebo treatment, and followed up for 36 weeks. Treatment response was based on joint pain/ tenderness and swelling scores and physician and patient global assessments. Longitudinal analysis revealed a trend favoring SSZ treatment (P = 0.13). At the end of treatment, response rates were 57.8% for SSZ compared with 44.6% for placebo (P = 0.05). The Westergren erythrocyte sedimentation rate declined more in the PsA patients taking SSZ than in those taking placebo (P < 0.0001). Adverse reactions were fewer than expected and were mainly due to nonspecific gastrointestinal complaints, including dyspepsia, nausea, vomiting, and diarrhea. SSZ at a dosage of 2,000 mg/day is well tolerated and may be more effective than placebo in the treatment of patients with PsA.

References

Feb 1, 1990·British Journal of Rheumatology·M FarrP A Bacon
Sep 1, 1988·Clinical Rheumatology·M FarrP A Bacon
Oct 1, 1993·British Journal of Rheumatology·S M FraserH A Bird

❮ Previous
Next ❯

Citations

Sep 1, 2005·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·G Wozel
Jan 25, 2006·Rheumatology International·U A WalkerS A Jurenz
Feb 28, 2006·Zeitschrift für Rheumatologie·J Braun, S Wassenberg
Jan 17, 2009·Zeitschrift für Rheumatologie·E Märker-Hermann, F Behrens
Sep 18, 2013·Zeitschrift für Rheumatologie·E Märker-Hermann
Jul 17, 2008·Clinical Rheumatology·Laura C Coates, Philip S Helliwell
Jan 9, 2013·Inflammation·Kemal ÜstünAhmet Mesut Onat
Aug 2, 2003·Journal of the American Academy of Dermatology·Eric M Ruderman
Jul 10, 2002·Joint, Bone, Spine : Revue Du Rhumatisme·Philippe Goupille
Jul 10, 2002·Joint, Bone, Spine : Revue Du Rhumatisme·Laurent MarguerieBernard Delcambre
Aug 26, 2006·Nature Clinical Practice. Rheumatology·Cailin Henderson, John C Davis
Sep 14, 2011·Nature Reviews. Rheumatology·Caroline A ChangPaul F Lizzul
Feb 22, 2012·Rheumatology·Gabrielle H KingsleyDavid L Scott
Jun 24, 2003·Current Opinion in Rheumatology·Juergen BraunJoachim Sieper
Jun 18, 2004·Current Opinion in Rheumatology·William J Taylor
Jun 18, 2004·Current Opinion in Rheumatology·Yan LiuMillicent A Stone
Jun 30, 2004·American Family Physician·Rajesh K Kataria, Lawrence H Brent
Jun 16, 2005·Current Opinion in Rheumatology·Jane Zochling, Jürgen Braun
Jun 16, 2005·Current Opinion in Rheumatology·Philip J Mease
Jun 10, 2006·Current Opinion in Rheumatology·Filip Van den BoschHerman Mielants
May 23, 2009·Current Opinion in Rheumatology·Philip J Mease
Jul 11, 2008·Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine·Robert H BrophyRussell F Warren
Jan 5, 2011·International Journal of Rheumatic Diseases·Fabrizio CantiniEmanuele Cassarà
Feb 15, 2005·Annals of the Rheumatic Diseases·P Nash, D O Clegg
Feb 15, 2005·Annals of the Rheumatic Diseases·N Bellamy
Jan 29, 2005·Annals of the Rheumatic Diseases·C AntoniUNKNOWN IMPACT 2 Trial Investigators
Feb 15, 2005·Annals of the Rheumatic Diseases·D D GladmanP Nash
Feb 15, 2005·Annals of the Rheumatic Diseases·P J MeaseW J Taylor
Dec 21, 2006·Annals of the Rheumatic Diseases·B Vander CruyssenF Van den Bosch
Oct 14, 2006·Annals of the Rheumatic Diseases·D E FurstM H Weisman
Sep 6, 2005·Journal of Immune Based Therapies and Vaccines·Sarah Cassell, Arthur Kavanaugh
Oct 24, 2009·Arthritis Research & Therapy·Jaap Fransen, Piet L C M van Riel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.